Generic Name
Deflazacort
Brand Names
Kymbee, Emflaza, Jaythari, Pyquvi
FDA approval date: September 10, 2018
Classification: Corticosteroid
Form: Tablet, Suspension
What is Kymbee (Deflazacort)?
Deflazacort tablets are indicated for the treatment of Duchenne muscular dystrophy in patients 5 years of age and older. Additional pediatric use information is approved for PTC Therapeutics, Inc.'s Emflaza TM tablets. However, due to PTC Therapeutics, Inc.'s marketing exclusivity rights, this drug product is not labeled with that information. Deflazacort tablets are corticosteroid indicated for the treatment of Duchenne muscular dystrophy in patients 5 years of age and older.
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment